Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 38, 2024 - Issue 3
229
Views
4
CrossRef citations to date
0
Altmetric
Research Article

A cularine-type isoquinoline alkaloid from the root part of Cissampelos pareira

, &
Pages 440-446 | Received 21 Jun 2022, Accepted 10 Sep 2022, Published online: 23 Sep 2022
 

Abstract

One cularine-type alkaloid (1) was isolated along with two known compounds (2 and 3) from the roots of Cissampelos pareira. The isolated compound’s chemical structures were elucidated by 1 D and 2 D NMR spectroscopy and mass spectrometry analysis. This is the first report on the cularine-type alkaloid from the genus Cissampelos. Compound (2) was reported for the first time from C. pareira. In silico molecular docking analysis showed various interactions of compounds with the active site residue of GABAA receptor, which could help to understand their putative mode of action in neurodevelopmental malfunctions and in anaesthesia.

Graphical Abstract

Acknowledgment

We are thankful to the Director, CSIR-IHBT, Palampur, for providing the necessary facilities. Ms. Surekha Kumari and Mr. Anmol are grateful to CSIR, New Delhi, and DST-INSPIRE for Senior Research Fellowships, respectively. CSIR-IHBT Communication No. 5106

Disclosure statement

The authors report no conflict of interest.

Additional information

Funding

This activity was supported by CSIR (MLP0159).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.